Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma.

The Journal of allergy and clinical immunology - 1 Dec 2005

Silkoff Philip E, Lent Anne M, Busacker Ashley A, Katial Rohit K, Balzar Silvana, Strand Matthew, Wenzel Sally E

Abstract excerpt

BACKGROUND: The fractional concentration of exhaled nitric oxide (FENO) is increased in asthma, correlates with eosinophilic inflammation, and decreases after steroid therapy. OBJECTIVE: We sought to examine whether persistent eosinophilia would be accompanied by an increased FENO level despite s...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Phenotype
Share to Asthma
Share to Biopsy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breath Tests

Share to Cross-Sectional Studies

Share to Eosinophilia

Share to Nitric Oxide

Share to ROC Curve

Source

Identifiers

PMID: 16337453
DOI: 10.1016/j.jaci.2005.09.029

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-16337453-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma.PMID 16337453Read ↗

Revisiting the role of exhaled nitric oxide in asthma.Semantic proximity Read ↗

MODERN APPROACHES TO FRACTIONAL EXHALED NITRIC OXIDE AS A USEFUL BIOMARKER FOR ALLERGIC ASTHMA PHENOTYPING AND MANAGEMENT.Semantic proximity Read ↗

Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma.Semantic proximity Read ↗

FeNO as biomarker for asthma phenotyping and management.Semantic proximity Read ↗

Predictive value of exhaled nitric oxide in the management of asthma: a systematic review.Semantic proximity Read ↗

Perspectives on exhaled nitric oxide.Semantic proximity Read ↗

Simultaneously elevated FeNO and blood eosinophils relate to asthma morbidity in asthmatics from NHANES 2007-12.Semantic proximity Read ↗

Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes.Semantic proximity Read ↗

Effects of steroid therapy on inflammatory cell subtypes in asthma.Semantic proximity Read ↗

A Review of the Utility and Cost Effectiveness of Monitoring Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management.Semantic proximity Read ↗

Reference values and determinants of fractional exhaled nitric oxide in a representative adult population in Western SwedenSemantic proximity Read ↗

Cutoff point for exhaled nitric oxide corresponding to 3% sputum eosinophils.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.